Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercializationDALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. NASDAQ:MGRX (“Mangoceuticals” or the “Company”), a company focused on developing, marketing…